Bagnarelli P, Menzo S, Valenza A, Manzin A, Giacca M, Ancarani F, Scalise G, Varaldo P E, Clementi M
Institute of Microbiology, University of Ancona Medical School, Italy.
J Virol. 1992 Dec;66(12):7328-35. doi: 10.1128/JVI.66.12.7328-7335.1992.
Recent molecular evidence indicates that active human immunodeficiency virus type 1 (HIV-1) infection is detectable in both symptomless and symptomatic infected patients. For this main reason, it has been pointed out that precise quantitative analysis of viral activity in vivo is necessary, firstly, for the pathogenetic investigation of the steps relevant to infection progression and, secondly, for better clinical management of HIV-1-infected patients. In this study, the presence of HIV-1 genomic RNA in plasma samples, specific HIV-1 transcripts in peripheral blood mononuclear cells, and proviral DNA sequences were assayed for 33 HIV-1-infected patients (including symptomless and symptomatic subjects) by using a competitive polymerase chain reaction method that allows quantitation of the RNA/DNA target sequences. The quantitative results obtained confirm that transcription of HIV-1 structural genes and complete viral replication occur in all the HIV-1-infected patients independently of the clinical stage. However, although sharp individual differences were detected, a high degree of correlation of the molecular parameters studied with both disease progression and a decrease in the number of CD4+ T lymphocytes was documented. Interestingly, despite the increasing viremia level associated with infection progression, the mean transcriptional activity of individual infected cells was found to be only moderately greater in AIDS patients than in asymptomatic infected subjects. In addition, it was noted that quantitation of HIV-1 genomic RNA in plasma samples and quantitation of specific HIV-1 transcripts in peripheral blood mononuclear cells appear to be more reliable and sensitive markers of viral activity than quantitative analysis of proviral HIV-1 sequences in peripheral lymphocytes.
最近的分子证据表明,在无症状和有症状的人类免疫缺陷病毒1型(HIV-1)感染患者中均能检测到活跃的HIV-1感染。主要基于这一原因,有人指出,首先,为了对与感染进展相关的步骤进行发病机制研究;其次,为了更好地临床管理HIV-1感染患者,对体内病毒活性进行精确的定量分析是必要的。在本研究中,通过使用一种能对RNA/DNA靶序列进行定量的竞争性聚合酶链反应方法,对33例HIV-1感染患者(包括无症状和有症状个体)的血浆样本中的HIV-1基因组RNA、外周血单核细胞中的特异性HIV-1转录本以及前病毒DNA序列进行了检测。获得的定量结果证实,HIV-1结构基因的转录和完整的病毒复制在所有HIV-1感染患者中均会发生,与临床阶段无关。然而,尽管检测到明显的个体差异,但所研究的分子参数与疾病进展以及CD4+T淋巴细胞数量减少之间存在高度相关性。有趣的是,尽管随着感染进展病毒血症水平升高,但发现艾滋病患者个体感染细胞的平均转录活性仅比无症状感染个体略高。此外,还注意到,血浆样本中HIV-1基因组RNA的定量以及外周血单核细胞中特异性HIV-1转录本的定量,似乎比外周淋巴细胞中前病毒HIV-1序列的定量分析更可靠、更敏感地反映病毒活性。